Protagenic Therapeutics Financial Overview
Protagenic Therapeutics's market cap is currently $2.38M. The company's EPS TTM is $-15.832; its P/E ratio is -0.17; Protagenic Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
